C16orf54 and thyroid cancer: Furthermore, immunohistochemical results showed that protein levels of C16orf54 in endometrial cancer, thyroid cancer, liver cancer, and urothelial cancer were decreased compared with those in normal tissues (Figures 1(f)–1(i)).